Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkerscreening Via Transcriptome and Methylosome Analysis in Cervical Cancer and Its Preinvasive Lesions

NCT02238990 is registered in ClinicalTrials.gov with University of Luebeck as lead sponsor.

NCT NCT02238990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02238990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkerscreening Via Transcriptome and Methylosome Analysis in Cervical Cancer and Its Preinvasive Lesions
Lead sponsor
University of Luebeck
Phase
Observational
Overall status
Active, not recruiting
Start date
September 30, 2014
Completion date
December 1, 2030
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evaluation of new tissue biomarkers for cervical cancer